You are here
Articles on Gastrointestinal Cancer
A selection of peer-reviewed articles on Gastrointestinal Cancer. All content available on the Advances in Gastrointestinal Cancer Resource Center, including original and review articles, interviews, guidelines and congress highlights, is independently selected by the members of the Editorial Board.
Grillo F, Fassan M, Sarocchi F, Fiocca R, Mastracci L.World J Gastroenterol 2016 Jul 14;22(26):5879-87.
Chan BA, Jang RW, Wong RK, Swallow CJ, Darling GE, Elimova E.Oncology (Williston Park) 2016 Jul;30(7):635-45. Review.
A Randomized Phase II Study of FOLFOX With or Without the MET Inhibitor Onartuzumab in Advanced Adenocarcinoma of the Stomach and Gastroesophageal Junction
Shah MA, Cho JY, Tan IB, Tebbutt NC, Yen CJ, Kang A, et al.Oncologist. 2016 Jul 8. [Epub ahead of print]
Clinical role of ramucirumab alone or in combination with paclitaxel for gastric and gastro-esophageal junction adenocarcinoma
Davidson M, Smyth EC, Cunningham D.Onco Targets Ther 2016;9:4539–48.
Eradication of Helicobacter pylori and Gastric Cancer: A Systematic Review and Meta-analysis of Cohort Studies
Doorakkers E, Lagergren J, Engstrand L, Brusselaers N.J Natl Cancer Inst 2016 Jul 14;108(9)
Yang JY, Lee HJ, Kim TH, Huh YJ, Son YG, Park JH, et al.Ann Surg Oncol 2016 Aug 3. [Epub ahead of print]
Yield of Staging Laparoscopy and Lavage Cytology for Radiologically Occult Peritoneal Carcinomatosis of Gastric Cancer
Ikoma N, Blum M, Chiang YJ, Estrella JS, Roy-Chowdhuri S, Fournier K, et al.Ann Surg Oncol 2016 Jul 6. [Epub ahead of print]
Is Centralization Needed for Esophageal and Gastric Cancer Patients With Low Operative Risk?: A Nationwide Study
Pasquer A, Renaud F, Hec F, Gandon A, Vanderbeken M, Drubay V, et al.Ann Surg 2016 Jul 15. [Epub ahead of print]
Phase II study of the effectiveness and safety of trastuzumab and paclitaxel for taxane- and trastuzumab-naïve patients with HER2-positive, previously treated, advanced or recurrent gastric cancer (JFMC45-1102)
Nishikawa K, Takahashi T, Takaishi H, Miki A, Noshiro H, Yoshikawa T, et al.Int J Cancer 2016 Aug 13. [Epub ahead of print]
EGFR gene amplification is relatively common and associates with outcome in intestinal adenocarcinoma of the stomach, gastro-oesophageal junction and distal oesophagus
Birkman E-M, Ålgars A, Lintunen M, Ristamäki R, Sundström J, Carpén OBMC Cancer. 2016; 16: 406.